These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25502427)

  • 1. Genetic risk assessment for breast and gynecological malignancies.
    Profato JL; Arun BK
    Curr Opin Obstet Gynecol; 2015 Feb; 27(1):1-5. PubMed ID: 25502427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-generation sequencing for hereditary breast and gynecologic cancer risk assessment.
    Kurian AW; Kingham KE; Ford JM
    Curr Opin Obstet Gynecol; 2015 Feb; 27(1):23-33. PubMed ID: 25502425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary breast-ovarian cancer: clinical findings and medical management.
    Marshall M; Solomon S
    Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary gynecologic cancers: risk assessment, counseling, testing and management.
    Ballinger LL
    Obstet Gynecol Clin North Am; 2012 Jun; 39(2):165-81. PubMed ID: 22640709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Issues of concern in risk assessment, genetic counseling, and genetic testing of younger breast cancer patients in Japan.
    Bando H
    Breast Cancer; 2014 Nov; 21(6):656-63. PubMed ID: 23754181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation and management of women with BRCA1/2 mutations.
    Peshkin BN; Isaacs C
    Oncology (Williston Park); 2005 Oct; 19(11):1451-9; discussion 1459-68 1474. PubMed ID: 16370446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical management of patients at inherited risk for gynecologic cancer.
    Powell CB
    Curr Opin Obstet Gynecol; 2015 Feb; 27(1):14-22. PubMed ID: 25490378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. US panel rejects routine use of BRCA cancer screening in women.
    McCarthy M
    BMJ; 2013 Apr; 346():f2160. PubMed ID: 23558348
    [No Abstract]   [Full Text] [Related]  

  • 9. Hereditary breast cancer: an update on risk assessment and genetic testing in 2015.
    Stuckey AR; Onstad MA
    Am J Obstet Gynecol; 2015 Aug; 213(2):161-5. PubMed ID: 25747548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of genetic testing for cancer susceptibility in gynecologic practice.
    Karlan BY; Berchuck A; Mutch D
    Obstet Gynecol; 2007 Jul; 110(1):155-67. PubMed ID: 17601911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic testing by cancer site: breast.
    Shannon KM; Chittenden A
    Cancer J; 2012; 18(4):310-9. PubMed ID: 22846731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.
    Antoniou AC; Durocher F; Smith P; Simard J; Easton DF;
    Breast Cancer Res; 2006; 8(1):R3. PubMed ID: 16417652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer risk assessment and the genetic counseling process: using hereditary breast and ovarian cancer as an example.
    Prucka SK; McIlvried DE; Korf BR
    Med Princ Pract; 2008; 17(3):173-89. PubMed ID: 18408385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Considerations in genetic counseling for inherited breast cancer predisposition.
    Robson ME; Offit K
    Semin Radiat Oncol; 2002 Oct; 12(4):362-70. PubMed ID: 12382194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decisions and ethical issues among BRCA carriers and the use of preimplantation genetic diagnosis.
    Quinn GP; Vadaparampil ST; Bower B; Friedman S; Keefe DL
    Minerva Med; 2009 Oct; 100(5):371-83. PubMed ID: 19910890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
    Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
    Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
    Chompret A
    J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of mathematical models for breast cancer risk assessment in routine clinical use.
    Fasching PA; Bani MR; Nestle-Krämling C; Goecke TO; Niederacher D; Beckmann MW; Lux MP
    Eur J Cancer Prev; 2007 Jun; 16(3):216-24. PubMed ID: 17415092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary predisposition to ovarian cancer, looking beyond BRCA1/BRCA2.
    Minion LE; Dolinsky JS; Chase DM; Dunlop CL; Chao EC; Monk BJ
    Gynecol Oncol; 2015 Apr; 137(1):86-92. PubMed ID: 25622547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal selection of individuals for BRCA mutation testing: a comparison of available methods.
    James PA; Doherty R; Harris M; Mukesh BN; Milner A; Young MA; Scott C
    J Clin Oncol; 2006 Feb; 24(4):707-15. PubMed ID: 16446345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.